| Application number | Title of the application | Filing Date | Status |
|---|
| 13/215394 | FERMENTATIVE PRODUCTION OF SOPHOROLIPIDS FROM SOYBEAN AND OTHER VEGETABLE OILS | Aug 22, 2011 | Abandoned |
Array
(
[id] => 8944181
[patent_doc_number] => 08497361
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-30
[patent_title] => 'Topoisomerase binding probe and method of use'
[patent_app_type] => utility
[patent_app_number] => 13/215175
[patent_app_country] => US
[patent_app_date] => 2011-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 12
[patent_no_of_words] => 7831
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13215175
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/215175 | Topoisomerase binding probe and method of use | Aug 21, 2011 | Issued |
Array
(
[id] => 8199527
[patent_doc_number] => 20120122935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-17
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING NECROTIZING ENTEROCOLITIS'
[patent_app_type] => utility
[patent_app_number] => 13/211229
[patent_app_country] => US
[patent_app_date] => 2011-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 9539
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20120122935.pdf
[firstpage_image] =>[orig_patent_app_number] => 13211229
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/211229 | COMPOSITIONS AND METHODS FOR TREATING NECROTIZING ENTEROCOLITIS | Aug 15, 2011 | Abandoned |
Array
(
[id] => 9648820
[patent_doc_number] => 08802832
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-12
[patent_title] => 'Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier'
[patent_app_type] => utility
[patent_app_number] => 13/198593
[patent_app_country] => US
[patent_app_date] => 2011-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12641
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13198593
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/198593 | Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier | Aug 3, 2011 | Issued |
Array
(
[id] => 8822161
[patent_doc_number] => 20130123206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-16
[patent_title] => 'TREATMENT OF METABOLIC SYNDROME AND INSULIN RESISTANCE WITH CITRUS FLAVANONES'
[patent_app_type] => utility
[patent_app_number] => 13/813072
[patent_app_country] => US
[patent_app_date] => 2011-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17981
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13813072
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/813072 | TREATMENT OF METABOLIC SYNDROME AND INSULIN RESISTANCE WITH CITRUS FLAVANONES | Jul 28, 2011 | Abandoned |
Array
(
[id] => 8976120
[patent_doc_number] => 20130209550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-15
[patent_title] => 'Anti-Viral Azide Containing Compounds'
[patent_app_type] => utility
[patent_app_number] => 13/812807
[patent_app_country] => US
[patent_app_date] => 2011-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16913
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13812807
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/812807 | Anti-Viral Azide Containing Compounds | Jul 27, 2011 | Abandoned |
Array
(
[id] => 9518843
[patent_doc_number] => 20140155336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-05
[patent_title] => 'WATER-SOLUBLE CAMPTOTHECIN DERIVATIVE, PHARMACEUTICAL COMPOSITION AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/235158
[patent_app_country] => US
[patent_app_date] => 2011-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7913
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14235158
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/235158 | Water-soluble camptothecin derivative, pharmaceutical composition and use thereof | Jul 26, 2011 | Issued |
Array
(
[id] => 8617350
[patent_doc_number] => 20130022663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-24
[patent_title] => 'Method of making and using a topical medicated formula and delivery system to use to prevent and treat breast diseases and breast cancer as well as use as skin wellness and anti-wrinkle formula'
[patent_app_type] => utility
[patent_app_number] => 13/135920
[patent_app_country] => US
[patent_app_date] => 2011-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3604
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13135920
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/135920 | Method of making and using a topical medicated formula and delivery system to use to prevent and treat breast diseases and breast cancer as well as use as skin wellness and anti-wrinkle formula | Jul 18, 2011 | Abandoned |
Array
(
[id] => 7663787
[patent_doc_number] => 20110313056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'GEL FORMATION OF POLYELECTROLYTE AQUEOUS SOLUTIONS BY THERMALLY INDUCED CHANGES IN IONIZATION STATE'
[patent_app_type] => utility
[patent_app_number] => 13/184953
[patent_app_country] => US
[patent_app_date] => 2011-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 13832
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0313/20110313056.pdf
[firstpage_image] =>[orig_patent_app_number] => 13184953
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/184953 | GEL FORMATION OF POLYELECTROLYTE AQUEOUS SOLUTIONS BY THERMALLY INDUCED CHANGES IN IONIZATION STATE | Jul 17, 2011 | Abandoned |
Array
(
[id] => 8301051
[patent_doc_number] => 20120183607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-19
[patent_title] => 'STABLE DOSAGE FORMS OF SPIRO AND DISPIRO 1,2,4-TRIOXOLANE ANTIMALARIALS'
[patent_app_type] => utility
[patent_app_number] => 13/183119
[patent_app_country] => US
[patent_app_date] => 2011-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7502
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13183119
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/183119 | Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials | Jul 13, 2011 | Issued |
Array
(
[id] => 7744320
[patent_doc_number] => 20120022012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'Glycosylated Acetaminophen Pro-Drug Analogs'
[patent_app_type] => utility
[patent_app_number] => 13/183222
[patent_app_country] => US
[patent_app_date] => 2011-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 22001
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20120022012.pdf
[firstpage_image] =>[orig_patent_app_number] => 13183222
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/183222 | Glycosylated acetaminophen pro-drug analogs | Jul 13, 2011 | Issued |
Array
(
[id] => 9047047
[patent_doc_number] => 08541600
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-24
[patent_title] => '11-aza, 11-thia and 11-oxa sterol compounds and compositions'
[patent_app_type] => utility
[patent_app_number] => 13/183275
[patent_app_country] => US
[patent_app_date] => 2011-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 168120
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13183275
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/183275 | 11-aza, 11-thia and 11-oxa sterol compounds and compositions | Jul 13, 2011 | Issued |
Array
(
[id] => 10161297
[patent_doc_number] => 09192507
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-24
[patent_title] => 'Tissue crosslinking for treatment of snoring and obstructive sleep apnea'
[patent_app_type] => utility
[patent_app_number] => 13/704220
[patent_app_country] => US
[patent_app_date] => 2011-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 6683
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13704220
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/704220 | Tissue crosslinking for treatment of snoring and obstructive sleep apnea | Jun 27, 2011 | Issued |
Array
(
[id] => 9273716
[patent_doc_number] => 08637648
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2014-01-28
[patent_title] => 'Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier'
[patent_app_type] => utility
[patent_app_number] => 13/165642
[patent_app_country] => US
[patent_app_date] => 2011-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11731
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13165642
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/165642 | Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier | Jun 20, 2011 | Issued |
Array
(
[id] => 7515529
[patent_doc_number] => 08039601
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2011-10-18
[patent_title] => 'Crystalline forms of 1,6-Bis [3-(3-carboxymethylphenyl)-4-(2-α-D-mannopyranosyloxy)-phenyl] hexane'
[patent_app_type] => utility
[patent_app_number] => 13/159875
[patent_app_country] => US
[patent_app_date] => 2011-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 16058
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/039/08039601.pdf
[firstpage_image] =>[orig_patent_app_number] => 13159875
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/159875 | Crystalline forms of 1,6-Bis [3-(3-carboxymethylphenyl)-4-(2-α-D-mannopyranosyloxy)-phenyl] hexane | Jun 13, 2011 | Issued |
Array
(
[id] => 7696158
[patent_doc_number] => 20110230432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'COMPOSITIONS AND KITS FOR TREATING INFLUENZA'
[patent_app_type] => utility
[patent_app_number] => 13/116484
[patent_app_country] => US
[patent_app_date] => 2011-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17487
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0230/20110230432.pdf
[firstpage_image] =>[orig_patent_app_number] => 13116484
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/116484 | COMPOSITIONS AND KITS FOR TREATING INFLUENZA | May 25, 2011 | Abandoned |
Array
(
[id] => 8043505
[patent_doc_number] => 20120071498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-22
[patent_title] => 'THERAPEUTIC COMPOSITION TO TREAT LESIONS CAUSED BY HERPES SIMPLEX VIRUS'
[patent_app_type] => utility
[patent_app_number] => 13/116112
[patent_app_country] => US
[patent_app_date] => 2011-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3467
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20120071498.pdf
[firstpage_image] =>[orig_patent_app_number] => 13116112
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/116112 | Therapeutic composition to treat lesions caused by herpes simplex virus | May 25, 2011 | Issued |
Array
(
[id] => 7580239
[patent_doc_number] => 20110294122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-01
[patent_title] => 'Synthesis of 2\', 3\'-Dideoxynucleosides for Automated DNA Synthesis and Pyrophosphorolysis Activated Polymerization'
[patent_app_type] => utility
[patent_app_number] => 13/117029
[patent_app_country] => US
[patent_app_date] => 2011-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11467
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0294/20110294122.pdf
[firstpage_image] =>[orig_patent_app_number] => 13117029
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/117029 | Synthesis of 2′,3′-dideoxynucleosides for automated DNA synthesis and pyrophosphorolysis activated polymerization | May 25, 2011 | Issued |
Array
(
[id] => 8490108
[patent_doc_number] => 20120289515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-15
[patent_title] => 'Combination therapy for cognitive distortions, resisting relapse of unipolar non-psychotic depression'
[patent_app_type] => utility
[patent_app_number] => 13/068946
[patent_app_country] => US
[patent_app_date] => 2011-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8410
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13068946
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/068946 | Combination therapy for cognitive distortions, resisting relapse of unipolar non-psychotic depression | May 24, 2011 | Abandoned |
Array
(
[id] => 9518852
[patent_doc_number] => 20140155344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-05
[patent_title] => 'COMBINATION THERAPY METHODS FOR TREATING PROLIFERATIVE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/701001
[patent_app_country] => US
[patent_app_date] => 2011-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 54748
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13701001
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/701001 | COMBINATION THERAPY METHODS FOR TREATING PROLIFERATIVE DISEASES | May 19, 2011 | Abandoned |